READCREST CAPITAL AG

Readcrest Capital reports, following the issuance of subscription shares (effective 27 July 2026), a new total number of voting rights of 46,902,379. There are no multiple voting rights. » Más en de.investing.com

Obotritia Capital KGaA bought a total of 180,134 Readcrest Capital shares on July 6, 2026, at a price of EUR 1.49 each. In FSE trading the Readcrest Capital share then gained, rising 12.80% to EUR 1.50. Readcrest Capital is listed with a market capitalization of EUR 49.19 million; the free float amounts to 33,235,700 shares. » Más en finanzen.net

The management board of Readcrest Capital expects adjusted EBITDA of €8.0 to €9.0 million for 2026. The figure comprises an EBITDA contribution from Grosvenor Health and Social Care of around €12 million, minus roughly €3–4 million from German project developments, and reflects the group structure adjusted after the sale of the UK care home business. Grosvenor remains the operating revenue and cash‑flow base, while Readcrest is simultaneously building a second growth pillar with value‑oriented real estate investments in German residential development projects. The adjusted EBITDA is an unaudited, non‑IFRS measure. » Más en finanzen.net